Diabetic Peripheral Neuropathy Market Growth Driven by Therapeutic Innovation
Diabetic peripheral neuropathy (DPN) is a frequent neurological complication of diabetes that develops when persistent blood glucose elevation damages peripheral nerves. Patients may experience burning pain, tingling, numbness, sensitivity changes, or reduced sensation, particularly in the feet, legs, and hands. Estimates suggest that around 60%–70% of individuals with diabetes may eventually develop some degree of peripheral neuropathy, although painful symptoms do not occur in every patient. Increasing diabetes prevalence, greater disease awareness, and demand for more effective pain-management strategies are supporting the expansion of the peripheral neuropathy market . DelveInsight's assessment examines epidemiology, treatment patterns, market trends, emerging therapies, and future opportunities across the United States, EU4, the United Kingdom, and Japan through 2034. Diabetic Peripheral Neuropathy Market and Growing Epidemiological Burden The increasing number of people af...